Liver Health & Hepatoprotection

GHK-Cu (copper peptide) is a naturally occurring tripeptide-copper complex with potent regenerative properties. Research shows it stimulates collagen synthesis, promotes wound healing, activates antioxidant enzymes, and may reset gene expression patterns associated with aging.

Topical application common for skin research. For systemic studies, subcutaneous injection is standard.

Tesamorelin is a stabilized synthetic analog of GHRH with a trans-3-hexenoic acid modification that extends its half-life. Research demonstrates significant effects on visceral fat reduction, IGF-1 elevation, and cognitive function in aging models.

Typically administered in the morning on an empty stomach. Reconstitute with sterile water for injection.

Tesamorelin 10mg is a high-dose vial of the FDA-approved synthetic GHRH analog (trade name Egrifta). It stimulates pulsatile GH release from the pituitary, leading to significant reductions in visceral adipose tissue (VAT), improved body composition, and emerging cognitive benefits. The 10mg vial provides extended protocol coverage for serious researchers.

Standard protocol: 2 mg/day SubQ. Reconstitute immediately before use — inject within 3 hours. 5/2 protocol (5 days on, 2 days off) also used.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It is one of the most extensively studied healing peptides, with remarkable regenerative effects on tendons, ligaments, muscles, the gut lining, and the nervous system. The 5mg vial provides a full research-grade supply for acute injury or maintenance protocols.

For acute injury: 500 mcg twice daily × 2 weeks. Maintenance: 250 mcg daily. Can be injected near injury site or systemically.